According to the data provided by the US Centers for Disease Control and Prevention (CDC), a new version of omicron has established itself in the United States. After a busy holiday travel season, the subvariant of omicron known as XBB.1.5 has caused concern regarding another potential wave of COVID-19 cases in the country. The CDC […]
Continue ReadingModerna Inc. claimed that its Omicron-focused COVID-19 vaccines had improved immune responses against BA.4 and BA.5 sub-variants of Omicron, found Moderna’s latest study. Data suggests that in adults who had been vaccinated and received booster shots, both of Moderna’s Omicron-focused vaccines, including mRNA-1273.214 and mRNA-1273.222, has produced high antibody response against BA.4 and BA.5 sub-variants […]
Continue Reading
The US Food and Drug Administration (FDA) authorized the updated COVID-19 booster vaccine shots from Pfizer, BioNTech and Moderns that mainly target the dominant BA.4 and BA.5 Omicron subvariants, as the government of the United States prepares for a vaccination campaign that can start in some days. Both COVID-19 vaccines also include the original version […]
Continue Reading
Pfizer Inc. and BioNTech announced they have completed a submission to the US Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of an Omicron adapted bivalent COVID-19 vaccine for individuals over 12 years. This application follows guidance from the US FDA to include clinical data from the bivalent Omicron […]
Continue Reading
According to the reports, just weeks after a new omicron subvariant has taken over as the dominant strain circulating in the United States and the two other subvariants have now entered the scene and are rapidly spreading in the United States. The BA.4 and BA.5 Omicron covid-19 variants, which had been first identified in the […]
Continue Reading
A large study of the fully vaccinated people of the United Kingdom, the illness caused by the Omicron covid-19 variant has been on a verge around two days shorter than the delta variant of the novel corona virus. The authors of the study said, the shorter presentation of the symptoms has been suggesting that, the […]
Continue Reading
According to the updated data by the US CDC, the BA.2 subvariant of the Omicron corona virus variant is making up around 35 percent of the new corona virus infections in the United States. This new data has been up from 22.3 percent in the previous week and 15.8 percent two weeks before, and the […]
Continue Reading
The pharmaceutical company ‘AstraZeneca’ said, the antibody-based cocktail of the company for the prevention and treatment of the novel corona virus had been showing to retain the neutralization activity against the Omicron corona virus variants that is including the highly contagious BA.2 sub variant of the Omicron in a study conducted by an independent lab. […]
Continue Reading
On Tuesday, 8th March 2022 said, the US CDC said, the BA.2 sub-variant of the Omicron covid-19 variant had been estimated for being 11.6 percent of the novel corona virus variants that are circulating in the United States as of 5th March 2022. The scientists have also been tracking an increase in the cases caused […]
Continue Reading
The Food and Drug Administration (FDA) of the United States have given the authorization for a new monoclonal antibody treatment that is working effectively against the Omicron covid-19 variant. The emergency use authorization for the bebtelovimab has been for the treatment of the mild to moderate corona virus in the adults and pediatric patients around […]
Continue Reading